Centralised authorisation procedure 2014
The Danish share of assignments in the European pharmaceutical collaboration.
The Danish Medicines Agency should have the greatest possible influence on decisions regarding new medicinal products and thereby the greatest possible influence on the future development of the European market for medicinal products.
Status for 2014 up to and including 4th quarter
Denmark was assigned 7 human rapporteur/co-rapporteur cases and 4 veterinary rapporteur/co-rapporteur case, which is respectively 4% and 18% of all assigned central procedure cases in 2014.
Figure 1: Amount of assigned (co)rapporteurships in the EU in 2014 up to and including 4th quarter
Figure 2. Share of human Rap/Co-rap cases
View table 1 – Assigned human rapporteur/co-rapporteur cases
Figure 3. Share of veterinary Rap/Co-rap cases
View table 2 - Assigned veterinary rapporteur/co-rapporteur cases